LL 291 (Scopohist-PE 8 mg / 1.25 mg / 20 mg)
Generic Name: chlorpheniramine/methscopolamine/phenylephrine
Pill imprint LL 291 has been identified as Scopohist-PE 8 mg / 1.25 mg / 20 mg.
ScopoHist-PE is used in the treatment of nasal congestion; rhinitis and belongs to the drug class upper respiratory combinations. Risk cannot be ruled out during pregnancy. ScopoHist-PE 8 mg / 1.25 mg / 20 mg is not a controlled substance under the Controlled Substance Act (CSA).
- Generic Name:
- LL 291
- 8 mg / 1.25 mg / 20 mg
- Elliptical / Oval
- Prescription only
- Drug Class:
- Upper respiratory combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Larken Laboratories Inc
- National Drug Code (NDC):
More about ScopoHist-PE (chlorpheniramine / methscopolamine / phenylephrine)
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Interactions
- Support Group
- 0 Reviews – Add your own review/rating
- Drug class: upper respiratory combinations
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2017 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.